Oshlack, Benjamin,Wright, Curtis,Prater, Derek Allan
申请号：
HK11107841.3
公开号：
HK1149722B
申请日:
2004.10.25
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
The invention is directed to sustained release formulations containing oxycodone or a pharmaceutically acceptable salt thereof which provide a mean C 24 /C max oxycodone ratio of 0.6 to 1.0 or 0.7 to 1 after oral administration at steady state to patients and methods thereof.
